Overview

Gender

male

Thom Rowland is an industry veteran who started his career as a sales representative for UCB Pharmaceuticals. Thom later held various marketing positions with UCB prior to taking the position of head of marketing for Scandipharm. He played a lead role in turning the Scandipharm business around prior to its sale to Axcan Pharmaceuticals.

Thom then served as a Vice President of Sales and Marketing for several business units at Solvay Pharmaceuticals where he was again instrumental in turning around an underperforming area. Thom was one of the founders of Ventrus Biosciences which completed a successful IPO in 2010.